REGENXBIO Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
RGNX Nasdaq 2836 www.regenxbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for REGENXBIO Inc.

Regenxbio stock gains on positive gene therapy trial data - Sep 25th, 2026 7:37 am
REGENXBIO Presents Positive Three-Year Durability Data for Surabgene Lomparvovec in Diabetic Retinopathy at Retina Society Annual Scientific Meeting - Sep 24th, 2026 5:17 pm
REGENXBIO to Participate in Upcoming Investor Conferences - Sep 8th, 2026 5:05 am
Regenxbio’s Gene Therapy Faces Another FDA Setback in Hunter Syndrome - Sep 4th, 2026 6:23 pm
RGNX Stock Slumps 25% on FDA Clinical Hold for RGX-121 Gene Therapy - Aug 25th, 2026 9:07 am
REGENXBIO Strengthens Board of Directors with Appointment of Greg Ciongoli - Aug 25th, 2026 5:05 am
Regenxbio’s RGX-121 Setback Carries A Potential Cash Risk, Warns Clear Street - Aug 25th, 2026 4:50 am
FDA places clinical hold on REGENXBIO’s RGX-121 in MPS II trial - Aug 25th, 2026 4:21 am
RGNX Stock On Track For Worst Day In Over Three Months — BofA Says Buy Despite ‘Disappointing’ FDA Hold On Gene Therapy - Aug 24th, 2026 1:18 pm
Sector Update: Healthcare Stocks Decline in Afternoon Trading - Aug 24th, 2026 11:50 am
Why Regenxbio Halted Its Gene Therapy Trial—and Why the Stock Is Tumbling - Aug 24th, 2026 8:18 am
Why Did RGNX Stock Crash Today? - Aug 24th, 2026 7:02 am
REGENXBIO Shares Plunge After FDA Places Clinical Hold on RGX-121 - Aug 24th, 2026 6:45 am
Safety concerns spur FDA to again halt testing of Regenxbio gene therapy - Aug 24th, 2026 5:55 am
REGENXBIO Announces Regulatory Update on RGX-121 for MPS II - Aug 24th, 2026 5:05 am
REGENXBIO Q2 Earnings Call Highlights - Aug 7th, 2026 5:03 am
Regenxbio Inc (RGNX) (Q2 2026) Earnings Call Highlights: Cash Runway Extended into Q4 2027 on ... - Aug 6th, 2026 1:02 pm
Regenxbio (RGNX) Beats Q2 Earnings and Revenue Estimates - Aug 6th, 2026 7:50 am
REGENXBIO Reports Second Quarter 2026 Financial Results and Operational Highlights - Aug 6th, 2026 5:05 am